Gastric microbiome profile throughout gastric carcinogenesis: beyond helicobacter.

BACKGROUND

Gastric dysbiosis has been hinted as a potential cause of gastric cancer. However, changes in microbiome throughout the major stages of gastric carcinogenesis remain mostly unknown.

OBJECTIVE

To describe gastric microbiome at different stages, analysing for the first time dysbiosis specifically in patients with early gastric cancer (EGC).

METHODS

Cross-sectional study including patients ( = 77) with endoscopically and histologically confirmed normal stomachs (controls;  = 25), advanced atrophic gastritis with intestinal metaplasia (IM;  = 18) and EGC ( = 34). Endoscopic biopsies from antrum and corpus ( = 154) were analyzed. Next-generation sequencing was performed characterizing microbial communities down to the species level based on full-length 16SrRNA gene profiling.

RESULTS

Significant differences were found in the microbiome profile between the groups. Firmicutes were more frequent ( = .012) and Proteobacteria were less frequent ( = .04) both in the IM and EGC when comparing to controls. Relative frequency of , when present, was much higher in the controls (83%) when comparing to the other groups (IM 1%, EGC 27%;  = .006), being the dominant bacteria only in the controls. Dysbiosis was present already and more significantly at the IM stage, with two bacteria progressively increasing from controls to IM then to cancer: from 1.48 to 3.9% ( = .014); and from 19.3 to 33.7% ( = .04), being the EGC dominant bacteria.

CONCLUSIONS

Our results confirm dominancy in non-atrophic stomachs and progressive dysbiosis throughout gastric carcinogenesis. but particularly is significantly increased in patients with EGC. Specific modulation of these bacteria may change gastric cancer risk.